跳至主要内容
临床试验/NCT07704437
NCT07704437已完成1 期

Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy

University Hospital of Split1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年4月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
PAED (pediatric anesthesia emergence delirium scale)

研究概览

简要总结

The aim of this study is to confirm the effectiveness of remimazolam in preventing delirium during emergence from anesthesia in children who will undergo elective procedures of tonsillectomy, adenotonsillectomy or adenoidectomy, aged 3-12 years, American Society of Anesthesiologists (ASA) physical status I. Children will be anesthetized with balanced anesthesia, maintained with sevoflurane and will be randomized in two groups. The first group will receive remimazolam before anesthesia, while the second will receive normal saline, both intravenously.

The main outcome of the study will be the presence/absence of delirium during anesthesia recovery, while the secondary outcome will be postoperative pain level, length of stay in the recovery room, presence of unwanted events in the recovery room, presence of postoperative mood changes, as well as parental satisfaction.

详细描述

The aim of this study is to confirm the effectiveness of remimazolam in preventing delirium during emergence from anesthesia in children who will undergo elective procedures of tonsillectomy, adenotonsillectomy or adenoidectomy, aged 3-12 years, ASA classification I. Children will be anesthetized with balanced anesthesia, maintained with sevoflurane and will be randomized in two groups. The first group will receive remimazolam before anesthesia, while the second will receive normal saline, both intravenously.

The main outcome of the study will be the presence/absence of delirium during anesthesia recovery, while the secondary outcome will be postoperative pain level, length of stay in the recovery room, presence of unwanted events in the recovery room, presence of postoperative mood changes, as well as parental satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status I
  • Children undergoing scheduled tonsillectomy/adenoidectomy or combined procedure

排除标准

  • American Society of Anesthesiologists (ASA) physical status > 1
  • Known hypersensitivity to remimazolam or other benzodiazepines

结局指标

主要结局

PAED (pediatric anesthesia emergence delirium scale)

时间窗: Perioperative - immediately after extubation and 3 times after that every 10 minutes

The PAED scale consists of 5 criteria that are scored using a 5-point scale. A score greater than 10 (or greater than 12) represents emergence delirium.

次要结局

  • FLACC ( Face, Legs, Activity, Cry, Consolability scale for assessing pain)(Perioperative - immediately after extubation and 3 times after that every 10 minutes)

研究者

发起方
University Hospital of Split
申办方类型
Other
责任方
Principal Investigator
主要研究者

Filip Peris

Anesthesiologist

University Hospital of Split

研究点 (1)

Loading locations...

相似试验

Remimazolam for Emergence Delirium Prevention in... | 临床试验